Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel El Fassi

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Ugeskrift for Laeger|September 28, 2018
[Eosinophilia]Ole Weis Bjerrum, Daniel El Fassi, Gitte Madsen, et al.
Journal of Internal Medicine|April 4, 2023
Neoehrlichia mikurensis-An emerging opportunistic tick-borne infection in immunosuppressed patientsRosa M M Gynthersen, Christen Rune Stensvold, Signe Ledou Nielsen, et al.
European Journal of Haematology|March 30, 2026
Incidence and Survival of Hemophagocytic Lymphohistiocytosis Over Two Decades: A Population-Based StudyMads Okkels Birk Lorenzen, Martin Jensen, Rasmus Rask Kragh Jørgensen, et al.
Cancer Immunology, Immunotherapy : CII|July 4, 2021
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trialStaffan Holmberg-Thydén, Inge Høgh Dufva, Anne Ortved Gang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 15, 2020
Hypercalcemia After Cosmetic Oil Injections: Unraveling Etiology, Pathogenesis, and SeverityEbbe Eldrup, Simone Theilade, Mette Lorenzen, et al.
Leukemia|October 8, 2022
Neoantigen reactive T cells correlate with the low mutational burden in hematological malignanciesSunil Kumar Saini, Staffan Holmberg-Thydén, Anne-Mette Bjerregaard, et al.
Hemasphere|August 16, 2021
A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic AnemiasAnnelies J van Vuren, Alaa Sharfo, Simon T Grootendorst, et al.
Frontiers in Immunology|March 13, 2023
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trialJacob Handlos Grauslund, Morten Orebo Holmström, Evelina Martinenaite, et al.
European Journal of Heart Failure|November 15, 2022
Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trialCamilla Fuchs Andersen, Massar Omar, Andreas Glenthøj, et al.
Frontiers in Immunology|May 23, 2022
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell SuppressionAna Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Ugeskrift for Laeger|September 28, 2018
[Eosinophilia]Ole Weis Bjerrum, Daniel El Fassi, Gitte Madsen, et al.
Journal of Internal Medicine|April 4, 2023
Neoehrlichia mikurensis-An emerging opportunistic tick-borne infection in immunosuppressed patientsRosa M M Gynthersen, Christen Rune Stensvold, Signe Ledou Nielsen, et al.
European Journal of Haematology|March 30, 2026
Incidence and Survival of Hemophagocytic Lymphohistiocytosis Over Two Decades: A Population-Based StudyMads Okkels Birk Lorenzen, Martin Jensen, Rasmus Rask Kragh Jørgensen, et al.
Cancer Immunology, Immunotherapy : CII|July 4, 2021
Epigenetic therapy in combination with a multi-epitope cancer vaccine targeting shared tumor antigens for high-risk myelodysplastic syndrome - a phase I clinical trialStaffan Holmberg-Thydén, Inge Høgh Dufva, Anne Ortved Gang, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 15, 2020
Hypercalcemia After Cosmetic Oil Injections: Unraveling Etiology, Pathogenesis, and SeverityEbbe Eldrup, Simone Theilade, Mette Lorenzen, et al.
Leukemia|October 8, 2022
Neoantigen reactive T cells correlate with the low mutational burden in hematological malignanciesSunil Kumar Saini, Staffan Holmberg-Thydén, Anne-Mette Bjerregaard, et al.
Hemasphere|August 16, 2021
A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic AnemiasAnnelies J van Vuren, Alaa Sharfo, Simon T Grootendorst, et al.
Frontiers in Immunology|March 13, 2023
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trialJacob Handlos Grauslund, Morten Orebo Holmström, Evelina Martinenaite, et al.
European Journal of Heart Failure|November 15, 2022
Effects of empagliflozin on erythropoiesis in heart failure: data from the Empire HF trialCamilla Fuchs Andersen, Massar Omar, Andreas Glenthøj, et al.
Frontiers in Immunology|May 23, 2022
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell SuppressionAna Micaela Carnaz Simões, Morten Orebo Holmström, Pia Aehnlich, et al.
Pageof 5